Zupan Bojana, Toth Miklos
Department of Pharmacology, Weill Medical College of Cornell University, New York, NY 10065, USA.
Results Probl Cell Differ. 2012;54:243-53. doi: 10.1007/978-3-642-21649-7_13.
Since fragile X syndrome (FXS) is a typical X-linked mendelian disorder, the protein product associated with the disease (FMRP) is absent or reduced not only in the affected individuals but, in case of full mutation, also in their mothers. Here, by using the mouse model of the disease, we provide evidence that hyperactivity, a typical symptom of FXS, is not wholly induced by the lack of Fmrp in mice but also occurs as a result of its reduced expression in their mother. Genetically wild-type offspring of mutant mothers also had hyperactivity, albeit less pronounced than the mutant offspring. However, other features of FXS reproduced in the mouse model, such as sensory hyperreactivity and seizure susceptibility, were exclusively associated with the absence of Fmrp in the offspring. These data indicate that fmr-1, the gene encoding Fmrp, can be both an offspring genetic and a maternal environmental factor in producing a neurodevelopmental condition.
由于脆性X综合征(FXS)是一种典型的X连锁孟德尔疾病,与该疾病相关的蛋白质产物(FMRP)不仅在受影响个体中缺失或减少,而且在完全突变的情况下,在其母亲中也会如此。在此,通过使用该疾病的小鼠模型,我们提供证据表明,多动作为FXS的典型症状,并非完全由小鼠中Fmrp的缺乏诱导产生,其母亲中Fmrp表达降低也会导致多动。突变母亲的基因野生型后代也有多动症状,尽管不如突变后代明显。然而,在小鼠模型中重现的FXS的其他特征,如感觉过敏和癫痫易感性,仅与后代中Fmrp的缺失有关。这些数据表明,编码Fmrp的基因fmr - 1在产生神经发育病症方面既可以是后代遗传因素,也可以是母体环境因素。